Paper8084592
Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.
Pastorek J and 9 others. Oncogene, 1994. Cited by 445 papers, by iCite.
Cite this record
ConductScience Library. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Papers, record 8084592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8084592
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Carbonic Anhydrases | Major topic |
| DNA-Binding Proteins | Major topic |
| Helix-Loop-Helix Motifs | Major topic |
| Neoplasm Proteins | Major topic |
| 3T3 Cells | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Carbonic Anhydrase IX | |
| Cloning, Molecular | |
| DNA, Neoplasm | |
| Glycosylation | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Protein Biosynthesis | |
| RNA, Messenger | |
| Sequence Homology, Amino Acid | |
| Zinc |
Source PubMed
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 445 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41977152 | High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977152 | PubMed |
| 41553426 | Achieving femtomolar affinities in structure-based drug design. | Eur Biophys J | 2026 | https://conductscience.org/library/papers/41553426 | PubMed |
| 41341048 | A Comparative Study of 157Gd and 10B Effect in a Carborane-Based Theranostic Agent for Membrane-Targeted Carbonic Anhydrase IX Inhibition and MRI-Guided Neutron Capture Therapy in Mesothelioma Treatment. | ACS Cent Sci | 2025 | https://conductscience.org/library/papers/41341048 | PubMed |
| 40371725 | Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies. | FEBS Open Bio | 2025 | https://conductscience.org/library/papers/40371725 | PubMed |
| 39596062 | Disruption of the Physical Interaction Between Carbonic Anhydrase IX and the Monocarboxylate Transporter 4 Impacts Lactate Transport in Breast Cancer Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596062 | PubMed |
| 38905127 | Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition. | J Enzyme Inhib Med Chem | 2024 | https://conductscience.org/library/papers/38905127 | PubMed |
| 38856178 | From X-ray crystallographic structure to intrinsic thermodynamics of protein-ligand binding using carbonic anhydrase isozymes as a model system. | IUCrJ | 2024 | https://conductscience.org/library/papers/38856178 | PubMed |
| 38750635 | High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX. | Bioconjug Chem | 2024 | https://conductscience.org/library/papers/38750635 | PubMed |
| 38725568 | Targeting hypoxia signaling pathways in angiogenesis. | Front Physiol | 2024 | https://conductscience.org/library/papers/38725568 | PubMed |
| 38217826 | Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/38217826 | PubMed |
| 38046334 | Selective Tumor Hypoxia Targeting Using M75 Antibody Conjugated Photothermally Active MoOx Nanoparticles. | ACS Omega | 2023 | https://conductscience.org/library/papers/38046334 | PubMed |
| 37880684 | [1, 8]-Naphthyridine derivatives as dual inhibitor of alkaline phosphatase and carbonic anhydrase. | BMC Chem | 2023 | https://conductscience.org/library/papers/37880684 | PubMed |
| 37446271 | Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446271 | PubMed |
| 36982873 | Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models-Implications for Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982873 | PubMed |
| 36902027 | Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902027 | PubMed |
| 36776327 | SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration. | Front Oncol | 2023 | https://conductscience.org/library/papers/36776327 | PubMed |
| 36718988 | Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/36718988 | PubMed |
| 36271018 | Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells. | Sci Rep | 2022 | https://conductscience.org/library/papers/36271018 | PubMed |
| 36100684 | Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia. | Sci Rep | 2022 | https://conductscience.org/library/papers/36100684 | PubMed |
| 36092600 | Structure and Dynamics of the Isozymes II and IX of Human Carbonic Anhydrase. | ACS Omega | 2022 | https://conductscience.org/library/papers/36092600 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CA9 | 768 | Swiss-Prot's references | https://conductscience.org/library/genes/768 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | X66839 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8084592
GET https://conductscience.org/api/papers/v1/8084592/cited_by?page=2